3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Stamulumab: new trials by email Literature Review of Stamulumab trials Research Report on Stamulumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Evaluating MYO-029 in Adult Muscular Dystrophy MYO-029 - Becker Muscular Dystrophy, Facioscapulohumeral Muscular Dystrophy | Phase 1 / Phase 2 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 108 | 2005-02-01 | 2007-12-28 |
| Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of MYO-029 MYO-029 - Healthy | Phase 1 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 72 | 2004-10-01 | 2007-11-26 |
| Safety and Tolerability Study of FG-3019 in Participants With Idiopathic Pulmonary Fibrosis FG-3019 - Idiopathic Pulmonary Fibrosis | Phase 1 | Completed | Kyntra Bio | 21 | 2003-12-08 | 2023-07-12 |
Idiopathic Pulmonary Fibrosis (1) · Muscular Dystrophies, Limb-Girdle (1) · Muscular Dystrophy, Duchenne (1) · Muscular Dystrophy, Facioscapulohumeral (1) · Pulmonary Fibrosis (1) · Respiration Disorders (1)
Wyeth is now a wholly owned subsidiary of Pfizer (2) · Kyntra Bio (1)
United States (2)